0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The role of blood neutrophil lymphocyte ratio in predicting the initial response to anti-VEGF treatment in neovascular AMD patients.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Vascular endothelial growth factor (VEGF) has a critical role in age-related macular degeneration (AMD), and intravitreal injection of anti-VEGF drugs is the mainstay of neovascular AMD treatment. Blood neutrophil-to-lymphocyte ratio (NLR) is shown to be a biomarker of inflammation in AMD. We aimed to investigate the role of NLR in predicting favorable short-term anti-VEGF treatment results in neovascular AMD patients.

          Related collections

          Author and article information

          Journal
          Ir J Med Sci
          Irish journal of medical science
          Springer Science and Business Media LLC
          1863-4362
          0021-1265
          Feb 2024
          : 193
          : 1
          Affiliations
          [1 ] Department of Ophthalmology, Dr. Abdurrahman Yurtaslan Oncology Research and Training Hospital, 06550, Yenimahalle, Ankara, Turkey. segokce@gmail.com.
          [2 ] Department of Ophthalmology, Dr. Abdurrahman Yurtaslan Oncology Research and Training Hospital, 06550, Yenimahalle, Ankara, Turkey.
          [3 ] Department of Ophthalmology, Ankara City Hospital, Ankara, Turkey.
          Article
          10.1007/s11845-023-03379-6
          10.1007/s11845-023-03379-6
          37247185
          7bbda0cf-33d6-4fd4-a9f5-1e59d816e935
          History

          Neutrophil lymphocyte ratio,Age-related macular degeneration,Anti-VEGF treatment

          Comments

          Comment on this article